The global cystatin C testing market was valued at around US$ 194.3 Mn at the end of 2021. The market is projected to register a 7.5% CAGR and top a valuation of US$ 400.4 Mn by 2032.
“Launch of various cystatin C testing kits and increasing prevalence of cystatin C-positive disorders among the population across the globe is expected to propel the cystatin C testing market growth.”
| Attributes | Details |
|---|---|
| Cystatin C Testing Market Value in 2021 | US$ 194.3 Million |
| Cystatin C Testing Market Value in 2032 | US$ 400.4 Million |
| Cystatin C Testing Market CAGR (2022 to 2032) | 7.5% |
The quantity of a protein, cystatin C in the blood is measured by the cystatin C test. Cystatin C is constantly created by the human body, and the protein is detected in several fluids, including spinal fluid, breast milk, and blood. The healthy kidneys sieve cystatin C from the blood so that it can be defecated in the urine.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The increasing prevalence of several disorders such as myocardial infarction, and muscular dystrophy is one of the major factors that is accelerating the market growth. Besides this, the favorable reimbursement policies in the healthcare sector are a great advantage for cystatin C testing.
Furthermore, the growth in the number of pathology laboratories, hospital laboratories, research labs, and diagnostic centers across the geographies is boosting the market growth for the cystatin C testing market. Apart from this, the low cost of the reagents is also one of the major market stimulating factors. The increased investments in the healthcare sector by the government organizations of several nations are also expected to favor the cystatin C testing market.
Moreover, the major businesses in the market are highly investing in research and development activities, to offer novel and high-quality testing kits and products to the end users such as diagnostic laboratories, clinics, and hospitals. Besides this, the key market players are concentrating on activities like mergers and acquisitions. Due to these activities, the market is expected to grow at a rapid pace in the near future.
North America held the largest share in the global cystatin C testing market and is expected to continue in the near future. The growing healthcare sector and the launch of novel products in the region are expected to accelerate the market during the forecast period. Europe is also estimated to witness lucrative growth over the projected period, owing to the advanced and developed healthcare facilities.
The increasing disposable income along with the rising health awareness, and increasing demand for diagnostic procedures especially in the geriatric population is the major factor that is expected to fuel the market growth in Asia Pacific Region.
Principal Consultant
Some of the key manufacturers operating in the cystatin C testing market are Abbott, Eurolyser Diagnostica, Randox Laboratories, DiaSys Diagnostic Systems, Diazyme Laboratories, Tosoh India Pvt. Ltd., BBI Solutions, PerkinElmer, Siemens Healthcare Private Limited, and Pointe Scientific Inc.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 7.5% 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Billion and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segment Covered | Product, Test, Application, End User, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel |
| Key Players | Abbott; Eurolyser Diagnostica; Randox Laboratories; DiaSys Diagnostic Systems; Diazyme Laboratories; Tosoh India Pvt. Ltd.; BBI Solutions; PerkinElmer; Siemens Healthcare Private Limited; Pointe Scientific Inc. |
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global cystatin C testing market is anticipated to register a CAGR of 7.5% during the forecast period.
Abbott, Eurolyser Diagnostica, Randox Laboratories, DiaSys Diagnostic Systems, Diazyme Laboratories, Tosoh India Pvt. Ltd., BBI Solutions, PerkinElmer, Siemens Healthcare Private Limited, and Pointe Scientific Inc. among others are some prominent cystatin C testing market players.
Explore Healthcare Insights
View Reports
Cystatin C Testing Market
